CRISPR Therapeutics (NASDAQ: CRSP) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that the U.S. Food and Drug Administration (FDA) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Management Comments

Vertex Pharma (VRTX) Expands Current Partnership with X-Chem Inc.January 4, 2019 8:17 AM CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell DiseaseJanuary 4, 2019 7:00 AM Celgene, TESARO Deals Positive for SMID Cap Biotech - SunTrustJanuary 3, 2019 10:34 AM